[go: up one dir, main page]

MX2010008720A - Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria. - Google Patents

Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.

Info

Publication number
MX2010008720A
MX2010008720A MX2010008720A MX2010008720A MX2010008720A MX 2010008720 A MX2010008720 A MX 2010008720A MX 2010008720 A MX2010008720 A MX 2010008720A MX 2010008720 A MX2010008720 A MX 2010008720A MX 2010008720 A MX2010008720 A MX 2010008720A
Authority
MX
Mexico
Prior art keywords
immune response
enhancing immune
respiratory condition
kits
compositions
Prior art date
Application number
MX2010008720A
Other languages
English (en)
Inventor
James Patrick Ebel
Jeffrey Warren Clymer
Lucy Anne Gildea
David Alexander Lawson
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2010008720A publication Critical patent/MX2010008720A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En la presente se describen composiciones para tratar una afección respiratoria, preferentemente, mediante la mejora de una respuesta inmunitaria en un mamífero. Las composiciones incluyen una cantidad terapéutica de una cepa de bacterias probióticas y una cantidad terapéutica de un componente adicional. También se incluyen métodos de tratamiento de una afección respiratoria, preferentemente, mediante la mejora de la respuesta inmunitaria en un mamífero. Los estuches contienen las composiciones, y también se incluyen las instrucciones para aplicar los métodos. El método incluye la administración oral al mamífero de una cantidad terapéutica de una cepa de bacterias probióticas y una cantidad terapéutica de un componente adicional.
MX2010008720A 2008-02-06 2009-02-06 Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria. MX2010008720A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6373508P 2008-02-06 2008-02-06
PCT/US2009/033391 WO2009100331A2 (en) 2008-02-06 2009-02-06 Compositions methods and kits for enhancing immune response to a respiratory condition

Publications (1)

Publication Number Publication Date
MX2010008720A true MX2010008720A (es) 2010-08-30

Family

ID=40791057

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008720A MX2010008720A (es) 2008-02-06 2009-02-06 Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.

Country Status (10)

Country Link
US (2) US20090196921A1 (es)
EP (1) EP2268793A2 (es)
JP (1) JP2011510684A (es)
CN (1) CN101939411A (es)
AU (1) AU2009212295A1 (es)
BR (1) BRPI0908348A2 (es)
CA (1) CA2713525A1 (es)
MX (1) MX2010008720A (es)
RU (1) RU2010132283A (es)
WO (1) WO2009100331A2 (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE549027T1 (de) * 2003-03-21 2012-03-15 K2A Llc Nahrungsergänzungsmittel auf basis von jucara- und acai-früchten
BG110506A (bg) * 2009-10-27 2011-05-31 "Селур Вк Холдинг" Еоод Нови щамове млечно-кисели бактерии и техни комбинации за получаване на пробиотични препарати
MX2012004777A (es) * 2009-10-30 2012-06-01 Nestec Sa Metodos para mantener la salud de los ojos y mejorar enfermedades oftalmicas en caninos.
TW201121431A (en) * 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
EP2585583A4 (en) * 2010-06-01 2014-01-15 Moore Res Entpr Llc CELLULAR CONSTITUENTS FROM BACTEROID GENE BACTERIA, COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC METHODS USING BACTEROID BACTERIA OR CELLULAR COMPONENTS THEREOF
HK1253538A1 (en) * 2010-08-04 2019-06-21 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
US20120135127A1 (en) * 2010-11-29 2012-05-31 Sheng Chun Tang Pharmaceutical Industrial Co., Ltd. Dispersion having particles of ganoderma lucidum
JP5840368B2 (ja) * 2011-02-02 2016-01-06 カルピス株式会社 関節炎予防改善用物質
WO2012140636A1 (en) * 2011-04-11 2012-10-18 Alimentary Health Limited A probiotic formulation
GB201110095D0 (en) * 2011-06-15 2011-07-27 Danisco Method of treatment
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
DE102012101864A1 (de) * 2012-03-06 2013-09-12 Gramme-Revit Gmbh Mittel zur Behandlung von Allergien und anderen Erkrankungen
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
WO2014141265A1 (en) * 2013-03-14 2014-09-18 Nofar Gil Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EA029476B1 (ru) * 2013-04-19 2018-03-30 Актиженомик Са Микропищевые добавки для иммунитета
WO2014195479A1 (en) * 2013-06-07 2014-12-11 Nerthus Aps Dry preparation of alpinia galanga or alpinia conchigera with high content of 1's-1'-acetoxychavicol acetate
EP3068404B1 (en) * 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
CN103734732B (zh) * 2014-01-27 2015-08-05 杨子驿 呼吸道保健的清咽利气食品
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US20170273326A1 (en) * 2014-08-29 2017-09-28 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacteria-containing composition
EP3015110A1 (en) * 2014-10-28 2016-05-04 D.M.G. Italia Srl Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
HUE037476T2 (hu) 2014-12-23 2018-08-28 4D Pharma Res Ltd Pirin polipeptid és immunmodulálás
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
TW202223083A (zh) 2015-06-15 2022-06-16 英商4D製藥研究有限公司 包含細菌菌株之組合物之用途
EA038405B1 (ru) 2015-06-15 2021-08-24 4Д Фарма Рисёрч Лимитед ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108135946A (zh) * 2015-08-27 2018-06-08 宝洁公司 长双歧杆菌
EP3341081B1 (en) * 2015-08-27 2020-11-11 PrecisionBiotics Group Limited Use of bifidobacterium longum and an exopolysaccharide produced thereby
US10300036B2 (en) 2015-10-05 2019-05-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung injury
CA3039393A1 (en) * 2015-10-07 2017-04-13 Bifodan A/S Probiotic formulation
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
PT3209310T (pt) 2015-11-20 2018-04-20 4D Pharma Res Ltd Composições compreendendo estirpes bacterianas
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201733601A (zh) 2016-03-04 2017-10-01 ４Ｄ製藥有限公司 包含細菌菌株之組合物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN110392734A (zh) 2017-02-28 2019-10-29 营养健康有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
MX379160B (es) * 2017-02-28 2025-03-11 Alimentary Health Ltd Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infección respiratoria por virus.
CN107080755A (zh) * 2017-04-28 2017-08-22 青岛东海药业有限公司 凝结芽孢杆菌在制备预防或治疗慢性阻塞性肺疾病制剂中的应用
CN106978464B (zh) * 2017-04-28 2021-04-23 华南农业大学 一种提高蛹虫草Cm04类胡萝卜素产量的固体发酵方法
MA48939B1 (fr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
GB201708932D0 (en) 2017-06-05 2017-07-19 Probi Ab Microbial compositions
TW201919670A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
DK3600363T3 (da) 2017-06-14 2021-01-25 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
CA3066557A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
US20180360811A1 (en) * 2017-06-16 2018-12-20 SEN-JAM Pharmaceutical LLC Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections
KR20200090729A (ko) * 2017-06-21 2020-07-29 가네덴 바이오테크, 인코포레이티드 비활성화 바실러스 코아귤란스와, 신체 활동능력을 증가시키기 위한 이의 용도
US9943503B1 (en) * 2017-10-19 2018-04-17 Edward Wick Pharmaceutical composition for treating bacterial and viral infections
JP7041272B2 (ja) 2018-01-12 2022-03-23 ジーアイ・イノベイション・インコーポレイテッド プロバイオティクスおよびＩｇＥへの結合親和性を有するポリペプチドを含む組成物およびその使用
IT201800003804A1 (it) * 2018-03-21 2019-09-21 Neilos S R L Composizione per il trattamento delle patologie respiratorie e orofaringee
NL2021737B1 (en) * 2018-10-01 2020-05-07 Nutricia Nv Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN110643542B (zh) * 2019-10-25 2021-01-29 江南大学 一株可缓解变应性哮喘Th2反应的罗伊氏乳杆菌及其应用
AU2020410965B2 (en) 2019-12-23 2025-12-11 Farmalíder, S.A Liquid composition comprising ibuprofen and phenylephrine
IT202000005011A1 (it) * 2020-03-09 2021-09-09 Sofar Spa Lattoferrina per uso orale ad azione antivirale
US20230098743A1 (en) * 2020-03-09 2023-03-30 Sofar S.P.A. Bacterial strains and compositions thereof for oral use in the treatment of viral infections of the respiratory system
WO2021180973A1 (en) * 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
IT202000006448A1 (it) 2020-03-26 2021-09-26 Sofar Spa Ceppi di batteri, loro composizioni e loro uso in un metodo per il trattamento di una carenza di vitamina d,e di disturbi associati
US20230158089A1 (en) * 2020-04-09 2023-05-25 Chandler Biopharmaceutical Corporation Probiotic compositions and methods of use
CN113558245B (zh) * 2020-04-28 2024-03-08 香港中文大学 用于提高免疫力的组合物
CN112056399A (zh) * 2020-06-28 2020-12-11 武汉康复得生物科技股份有限公司 一种增强免疫力的益生菌组合物及其应用
US11318174B2 (en) 2020-07-09 2022-05-03 Dupont Nutrition Biosciences Aps Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
CN111743922B (zh) * 2020-07-14 2022-03-29 华熙生物科技股份有限公司 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用
US20220040228A1 (en) * 2020-08-10 2022-02-10 Frank Gaertner Materials and methods for stopping respiratory virus infections
US20240000867A1 (en) * 2020-11-12 2024-01-04 Synbiotics Ab Synbiotic composition
US20220265738A1 (en) * 2021-02-12 2022-08-25 University Of South Florida Salutary effects of indigenous probiotics and nanoaerosol methods to mitigate microbial infections including covid 19
US12186358B2 (en) 2021-02-17 2025-01-07 Plexus Worldwide, Llc Compositions and methods for supporting immune health
EP4297736A1 (en) * 2021-02-23 2024-01-03 Société des Produits Nestlé S.A. Composition and kit for alleviating symptoms of respiratory allergy in toddlers
US20230113990A1 (en) * 2021-06-29 2023-04-13 Daniel E. Bucci Nutritional drink
TW202323517A (zh) * 2021-10-28 2023-06-16 香港中文大學 用於增強ｃｏｖｉｄ疫苗接種效力和減少來自ｃｏｖｉｄ疫苗接種的不良影響的組合物和方法
WO2023118979A1 (en) * 2021-12-22 2023-06-29 Novo Integrated Sciences Inc. System and method for antibody activators in an aqueous iodine solution
US20230217959A1 (en) * 2022-01-12 2023-07-13 Hillel Trope Dog biscuit
CN115737690B (zh) * 2022-11-11 2024-04-19 重庆医科大学 约氏乳杆菌在制备用于缓解急性呼吸窘迫综合征的药物中的应用
CN116726054B (zh) * 2022-12-05 2024-03-26 山东新时代药业有限公司 一种即食型益生菌组合物及其制备方法、用途
JP2025172664A (ja) * 2024-05-13 2025-11-26 我的輕食有限公司 微粒子状物質による肺損傷の改善用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69506550D1 (de) * 1994-07-14 1999-01-21 Du Pont Kühlzusammensetzungen
US7432097B2 (en) * 1997-08-13 2008-10-07 Verenium Corporation Phytases, nucleic acids encoding them and methods of making and using them
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
JP3633601B2 (ja) * 2001-04-27 2005-03-30 味の素株式会社 免疫賦活剤
US6764819B2 (en) * 2002-07-16 2004-07-20 Emp Biotech Gmbh Method for chemiluminescent detection
US20060263344A1 (en) * 2003-04-02 2006-11-23 Mitchell Skop Novel probiotic compositions and methods of using the same
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
WO2006048457A1 (en) * 2004-11-05 2006-05-11 Dsm Ip Assets B.V. Probiotica and polyphenol

Also Published As

Publication number Publication date
US20120114608A1 (en) 2012-05-10
CA2713525A1 (en) 2009-08-13
US20090196921A1 (en) 2009-08-06
CN101939411A (zh) 2011-01-05
WO2009100331A3 (en) 2009-12-17
AU2009212295A1 (en) 2009-08-13
EP2268793A2 (en) 2011-01-05
JP2011510684A (ja) 2011-04-07
BRPI0908348A2 (pt) 2015-07-28
RU2010132283A (ru) 2012-03-20
WO2009100331A2 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
MX2010008720A (es) Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.
MX2010005642A (es) Preparados, metodos y estuches para el tratamiento de la tos.
MX364200B (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
MX2010004494A (es) Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
IN2012DN01920A (es)
WO2012092364A3 (en) Method for sympathetic rebalancing of patient
EA201490004A1 (ru) Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
MY195289A (en) Anti IL-36R Antibodies
PH12014500075A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
WO2010062863A3 (en) Compositions containing satiogens and methods of use
MY157473A (en) Antibody molecules having specificity for human ox40
GB2503852A (en) Compounds for the treatment of neuropsychiatric disorders
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
WO2014043696A3 (en) Compositions and methods for treating amyotrophic lateral sclerosis
MX2018008882A (es) Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
WO2009008656A3 (en) A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
MX356814B (es) Métodos y composiciones para neuroprotección.
UA35047U (ru) Способ проведения оздоровительной гимнастики
UA56675U (ru) Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии
UA27828U (en) Method for treating prosthetic stomatitis against the background metabolic syndrome

Legal Events

Date Code Title Description
FA Abandonment or withdrawal